While Half of Facial Injectable Patients Request A Specific Product, Most Still Remain Unaware of Many Brands
TORONTO, Feb. 11, 2013 /PRNewswire/ — According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, just under half of all patients who received either a botulinum toxin (BTX) or dermal filler injection had requested a specified brand from their physicians. More than 60 percent of physicians comply with such requests. Nevertheless, most patients remain unaware of many available brands of facial injectables, and are even unclear on the differences between BTX and dermal fillers. Manufacturers of brands that are not top of mind will need to focus on education and awareness to compete successfully.
Millennium Research Group has produced two complementary Perception Pulse studies, Patient Insights in Facial Injectables and Physician Insights in Facial Injectables, both new for 2013, which analyze the United States market for facial injectables in detail. The results for the patient study are based on a survey of 210 patients in the US who recently received BTX or dermal filler injections. For the physician study, Millennium Research Group surveyed 272 physicians in the US who perform BTX or dermal filler injections, including plastic surgeons and dermatologists in addition to non-core specialties such as general practitioners, internists, dentists, ophthalmologists and otolaryngologists that increasingly perform such procedures.
“Physicians indicate that price has little impact on their decision to purchase and inject a particular BTX or dermal filler brand,” said MRG Senior Analyst Nick Morris. “Doctors continue to be willing to pay premium prices for brands they trust, especially when patients are consistently requesting those products by name.”
While physicians are aware of most brands, they are considerably less familiar with some of them, and are thus less likely to use them or talk to patients about them. Achieving higher levels of brand familiarity among both physicians and patients is a major challenge faced by many companies in the facial injectables market.
Millennium Research Group’s Perception Pulse reports provide unprecedented insight into the behaviors and preferences of those responsible for the purchase and use of medical devices, particularly illuminating why changes are happening in a particular market. Patient Insights in Facial Injectables and Physician Insights in Facial Injectables are essential tools for companies active in the US facial injectable market and looking to better understand brand perceptions and customer behaviors.
About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources Group company (www.DecisionResourcesGroup.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack(TM) projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.
About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.
All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.
For more information, contact:
Christopher Comfort Alex Jablokow Decision Resources Group Millennium Research Group 781-993-2597 617-599-8613 email@example.com firstname.lastname@example.org
SOURCE Millennium Research Group